BRL-44408
BRL-44408 is a drug used in scientific research which acts as a selective antagonist for the Alpha-2A [adrenergic receptor|α2A-adrenergic receptor]. It has been suggested as having potential therapeutic application in the treatment of extrapyramidal side effects produced by some antipsychotic medications.